Hollie Franklin, Author at Drugs in Context

Emollient treatment of atopic dermatitis: latest evidence and clinical considerations

Kam Lun Hon MBBS, MD, FAAP, FCCM, Jeng Sum Charmaine Kung BSc, Wing Gi Gigi Ng BSc, Ting Fan Leung MBChB, MD, MRCP, FRCPCH

Article Type

Review

Published

17 Apr 2018

This article reviews current classes of emollients in the market, their clinical evidence in atopic dermatitis and considerations for choice of an emollient.

Administration of intravenous morphine for acute pain in the emergency department inflicts an economic burden in Europe

Montserrat Casamayor MD, PhD, Karen DiDonato MSN, RN, Marc Hennebert MBA, MS, Luca Brazzi MD, PhD, Gregor Prosen MD, FEBEM

Article Type

Original Research

Published

11 Apr 2018

This article estimates the burden of IV administration of morphine in the five key European countries (EU5) using a micro-costing approach.

Atopic dermatitis: a review of topical nonsteroid therapy

Ariana Papier BA, Lindsay C Strowd MD

Article Type

Review

Published

04 Apr 2018

This review focuses on the safety and efficacy of topical calcineurin and PDE4 inhibitors for the treatment of atopic dermatitis.

High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease

Constantine E Kosmas MD, PhD, Ian Martinez MD, Andreas Sourlas, Kyriaki V Bouza MD, Frederick N Campos MD, Verenisse Torres MD, Peter D Montan MD, Eliscer Guzman MD

Article Type

Review

Published

28 Mar 2018

This review aims to present and discuss the current clinical and scientific evidence pertaining to the significance of HDL functionality over the actual HDL-C concentration in mediating the favorable effects on the cardiovascular system.

Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV

Milena M McLaughlin PharmD, MSc, Aimee J Guerrero BS, Andrew Merker PharmD

Article Type

Review

Published

21 Mar 2018

Reviews literature published regarding non-tenofovir antiretroviral agents causing renal adverse effects.